Navigation Links
Shire to Present at the Cowen 35th Annual Healthcare Conference
Date:2/25/2015

LEXINGTON, Massachusetts, February 25, 2015 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that Flemming Ornskov, MD, Chief Executive Officer, will present at the Cowen 35th Annual Healthcare Conference in Boston, MA on Tuesday, March 3, 2015 at 9:20 a.m. ET (2:20 p.m. GMT).

A live audio webcast will be available on the Presentations and Webcasts section of Shire's Investor website at http://www.shire.com/shireplc/en/investors/presentationswebcasts.

Subsequently, a replay of the webcast will be available on this same website for approximately 90 days.

NOTES TO EDITORS 

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We focus on providing treatments in Rare Diseases, Neuroscience, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmics.

http://www.shire.com

For further information please contact:

Investor Relations
Sarah Elton-Farr, seltonfarr@shire.com, +44-1256-894157

Media:
Stephanie Fagan, sfagan@shire.com, +1-201-572-9581
Jessica Cotrone, jcotrone@shire.com, +1-781-482-9538


'/>"/>
SOURCE Shire plc
Copyright©2015 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Transwestern
2. RBJ Advises Shire in 202,000 SF Lease, Creating Bostons Largest Suburban Biotech Campus
3. Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Bostons Largest Suburban Biotech Campus
4. Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers
5. The quantum Cheshire cat: Scientists separate a particle from its properties
6. Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
7. Shire plc - Statement re: Media Speculation
8. Shire Launches Online Educational Resource Center for US Patients with Ulcerative Colitis
9. Hart-Scott-Rodino Waiting Period Expires for Shires Acquisition of ViroPharma
10. Shire plc: Strong Third Quarter and Increased Non GAAP Earnings Expectations
11. Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary ... Cells Inc. (PSC) , has announced that their GMP facility for cell production ... Branch for manufacturing. This is an important milestone for VetStem as it ...
(Date:5/31/2019)... California (PRWEB) , ... May ... ... of our patent applications from the USPTO providing proprietary interest to our ... METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including ...
(Date:5/22/2019)... (PRWEB) , ... May 22, 2019 , ... Artemis ... closed a $8 million Series A funding round co-led by Astanor Ventures ... Empire State Development Fund and iSelect Fund . The company has raised ...
(Date:5/14/2019)... ... May 13, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ ... The redesigned website aims to improve LDA’s ability to communicate directly with the ...
Breaking Biology Technology:
(Date:7/5/2019)... ... July 05, 2019 , ... ... its patented Tractus™ Platform to governments around the world. , Powered by ... and point of care solutions to operating theatres worldwide to address new global ...
(Date:6/25/2019)... ... June 25, 2019 , ... ActX has launched a medical ... from 23andMe, customers can get access to professionally reviewed genetic screening similar to ... Ancestry and Health + Ancestry customers., With the ActX + 23andMe service, both ...
(Date:6/20/2019)... Fla. (PRWEB) , ... June 19, 2019 , ... ... recently announced by the Infectious Diseases Society of America Foundation, and the possibly ... on Aging to study infectious agents in AD, are a “welcome affirmation” of ...
Breaking Biology News(10 mins):